Association of bromodomain BET proteins with chromatin requires dimerization through the conserved motif B

Journal of Cell Science

Volumn 125, Issue 15, 2012, Pages 3671-3680

  Garcia Gutierrez, Pablo ^a   Mundi, Maria ^a   Garcia Dominguez, Mario ^a  

^a CSIC   (Spain)

Author keywords

Acetyl histone; BET proteins; Brd2; Bromodomain; Cell cycle; Dimerization

Indexed keywords

CYCLIN A2; CYCLIN D1; HISTONE DEACETYLASE; MEMBRANE PROTEIN; PROTEIN BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CHROMATIN; CHROMATIN STRUCTURE; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOSIS; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLATION; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN; CONSERVED SEQUENCE; DIMERIZATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEURONS; PROTEIN-SERINE-THREONINE KINASES; TRANSFECTION;

VERTEBRATA;

EID: 84869115753     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.105841     Document Type: Article

References (53)

1. Amoutzias, G. D., Robertson, D. L., Van de Peer, Y. and Oliver, S. G. (2008). Choose your partners: dimerization in eukaryotic transcription factors. Trends Biochem. Sci. 33, 220-229.
2. Bisgrove, D. A., Mahmoudi, T., Henklein, P. and Verdin, E. (2007). Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc. Natl. Acad. Sci. USA 104, 13690-13695.
3. Burnworth, B., Popp, S., Stark, H. J., Steinkraus, V., Bröcker, E. B., Hartschuh, W., Birek, C. and Boukamp, P. (2006). Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 25, 4399-4412.
4. Crawford, N. P., Alsarraj, J., Lukes, L., Walker, R. C., Officewala, J. S., Yang, H. H., Lee, M. P., Ozato, K. and Hunter, K. W. (2008). Bromodomain 4 activation predicts breast cancer survival. Proc. Natl. Acad. Sci. USA 105, 6380-6385.
5. Dawson, M. A., Prinjha, R. K., Dittmann, A., Giotopoulos, G., Bantscheff, M., Chan, W. I., Robson, S. C., Chung, C. W., Hopf, C., Savitski, M. M. et al. (2011). Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529-533.
6. Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J. et al. (2011). BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917.
7. Denis, G. V., Vaziri, C., Guo, N. and Faller, D. V. (2000). RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ. 11, 417-424.
8. Dey, A., Chitsaz, F., Abbasi, A., Misteli, T. and Ozato, K. (2003). The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. USA 100, 8758-8763.
9. Farah, M. H., Olson, J. M., Sucic, H. B., Hume, R. I., Tapscott, S. J. and Turner, D. L. (2000). Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development 127, 693-702.
10. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I. et al. (2010). Selective inhibition of BET bromodomains. Nature 468, 1067-1073.
11. Florence, B. and Faller, D. V. (2001). You bet-cha: a novel family of transcriptional regulators. Front. Biosci. 6, d1008-d1018.
12. French, C. A. (2012). Pathogenesis of NUT midline carcinoma. Annu. Rev. Pathol. 7, 247-265.
13. French, C. A., Miyoshi, I., Kubonishi, I., Grier, H. E., Perez-Atayde, A. R. and Fletcher, J. A. (2003). BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res. 63, 304-307.
14. French, C. A., Ramirez, C. L., Kolmakova, J., Hickman, T. T., Cameron, M. J., Thyne, M. E., Kutok, J. L., Toretsky, J. A., Tadavarthy, A. K., Kees, U. R. et al. (2008). BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27, 2237-2242.
15. Gamsjaeger, R., Webb, S. R., Lamonica, J. M., Billin, A., Blobel, G. A. and Mackay, J. P. (2011). Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3. Mol. Cell. Biol. 31, 2632- 2640.
16. Garcia-Dominguez, M., Poquet, C., Garel, S. and Charnay, P. (2003). Ebf gene function is required for coupling neuronal differentiation and cell cycle exit. Development 130, 6013-6025.
17. Garcia-Dominguez, M., March-Diaz, R. and Reyes, J. C. (2008). The PHD domain of plant PIAS proteins mediates sumoylation of bromodomain GTE proteins. J. Biol. Chem. 283, 21469-21477.
18. Giudicelli, F., Gilardi-Hebenstreit, P., Mechta-Grigoriou, F., Poquet, C. and Charnay, P. (2003). Novel activities of Mafb underlie its dual role in hindbrain segmentation and regional specification. Dev. Biol. 253, 150-162.
19. Greenwald, R. J., Tumang, J. R., Sinha, A., Currier, N., Cardiff, R. D., Rothstein, T. L., Faller, D. V. and Denis, G. V. (2004). E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia. Blood 103, 1475-1484.
20. Grigoryan, G. and Keating, A. E. (2008). Structural specificity in coiled-coil interactions. Curr. Opin. Struct. Biol. 18, 477-483.
21. Gyuris, A., Donovan, D. J., Seymour, K. A., Lovasco, L. A., Smilowitz, N. R., Halperin, A. L., Klysik, J. E. and Freiman, R. N. (2009). The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis. Biochim. Biophys. Acta 1789, 413-421.
22. Hebbes, T. R., Thorne, A. W. and Crane-Robinson, C. (1988). A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7, 1395- 1402.
23. Houzelstein, D., Bullock, S. L., Lynch, D. E., Grigorieva, E. F., Wilson, V. A. and Beddington, R. S. (2002). Growth and early postimplantation defects in mice deficient for the bromodomain-containing protein Brd4. Mol. Cell. Biol. 22, 3794- 3802.
24. Huang, H., Zhang, J., Shen, W., Wang, X., Wu, J., Wu, J. and Shi, Y. (2007). Solution structure of the second bromodomain of Brd2 and its specific interaction with acetylated histone tails. BMC Struct. Biol. 7, 57.
25. Huang, B., Yang, X. D., Zhou, M. M., Ozato, K. and Chen, L. F. (2009). Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 29, 1375-1387.
26. Ito, T., Umehara, T., Sasaki, K., Nakamura, Y., Nishino, N., Terada, T., Shirouzu, M., Padmanabhan, B., Yokoyama, S., Ito, A. et al. (2011). Real-time imaging of histone H4K12-specific acetylation determines the modes of action of histone deacetylase and bromodomain inhibitors. Chem. Biol. 18, 495-507.
27. Jeanmougin, F., Wurtz, J. M., Le Douarin, B., Chambon, P. and Losson, R. (1997). The bromodomain revisited. Trends Biochem. Sci. 22, 151-153.
28. Jenuwein, T. and Allis, C. D. (2001). Translating the histone code. Science 293, 1074- 1080.
29. Kanno, T., Kanno, Y., Siegel, R. M., Jang, M. K., Lenardo, M. J. and Ozato, K. (2004). Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell 13, 33-43.
30. Kruhlak, M. J., Hendzel, M. J., Fischle, W., Bertos, N. R., Hameed, S., Yang, X. J., Verdin, E. and Bazett-Jones, D. P. (2001). Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J. Biol. Chem. 276, 38307-38319.
31. Lamonica, J. M., Deng, W., Kadauke, S., Campbell, A. E., Gamsjaeger, R., Wang, H., Cheng, Y., Billin, A. N., Hardison, R. C., Mackay, J. P. et al. (2011). Bromodomain protein Brd3 associates with acetylated GATA1 to promote its chromatin occupancy at erythroid target genes. Proc. Natl. Acad. Sci. USA 108, E159- E168.
32. LeRoy, G., Rickards, B. and Flint, S. J. (2008). The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell 30, 51-60.
33. Lupas, A., Van Dyke, M. and Stock, J. (1991). Predicting coiled coils from protein sequences. Science 252, 1162-1164.
34. Mertz, J. A., Conery, A. R., Bryant, B. M., Sandy, P., Balasubramanian, S., Mele, D. A., Bergeron, L. and Sims, R. J., 3rd (2011). Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl. Acad. Sci. USA 108, 16669- 16674.
35. Mochizuki, K., Nishiyama, A., Jang, M. K., Dey, A., Ghosh, A., Tamura, T., Natsume, H., Yao, H. and Ozato, K. (2008). The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. J. Biol. Chem. 283, 9040-9048.
36. Morinière, J., Rousseaux, S., Steuerwald, U., Soler-López, M., Curtet, S., Vitte, A. L., Govin, J., Gaucher, J., Sadoul, K., Hart, D. J. et al. (2009). Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature 461, 664-668.
37. Nakamura, Y., Umehara, T., Nakano, K., Jang, M. K., Shirouzu, M., Morita, S., Uda-Tochio, H., Hamana, H., Terada, T., Adachi, N. et al. (2007). Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4. J. Biol. Chem. 282, 4193-4201.
38. O'Shea, E. K., Klemm, J. D., Kim, P. S. and Alber, T. (1991). X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254, 539-544.
39. Paillisson, A., Levasseur, A., Gouret, P., Callebaut, I., Bontoux, M., Pontarotti, P. and Monget, P. (2007). Bromodomain testis-specific protein is expressed in mouse oocyte and evolves faster than its ubiquitously expressed paralogs BRD2, -3, and -4. Genomics 89, 215-223.
40. Pao, P. C., Huang, N. K., Liu, Y. W., Yeh, S. H., Lin, S. T., Hsieh, C. P., Huang, A. M., Huang, H. S., Tseng, J. T., Chang, W. C. et al. (2011). A novel RING finger protein, Znf179, modulates cell cycle exit and neuronal differentiation of P19 embryonal carcinoma cells. Cell Death Differ. 18, 1791-1804.
41. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, 45e.
42. Prinjha, R. K., Witherington, J. and Lee, K. (2012). Place your BETs: the therapeutic potential of bromodomains. Trends Pharmacol. Sci. 33, 146-153.
43. Rahman, S., Sowa, M. E., Ottinger, M., Smith, J. A., Shi, Y., Harper, J. W. and Howley, P. M. (2011). The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol. Cell. Biol. 31, 2641-2652.
44. Sasaki, K., Ito, T., Nishino, N., Khochbin, S. and Yoshida, M. (2009). Real-time imaging of histone H4 hyperacetylation in living cells. Proc. Natl. Acad. Sci. USA 106, 16257-16262.
45. Seo, S., Richardson, G. A. and Kroll, K. L. (2005). The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD. Development 132, 105-115.
46. Shang, E., Wang, X., Wen, D., Greenberg, D. A. and Wolgemuth, D. J. (2009). Double bromodomain-containing gene Brd2 is essential for embryonic development in mouse. Dev. Dyn. 238, 908-917.
47. Sinha, A., Faller, D. V. and Denis, G. V. (2005). Bromodomain analysis of Brd2- dependent transcriptional activation of cyclin A. Biochem. J. 387, 257-269.
48. Umehara, T., Nakamura, Y., Jang, M. K., Nakano, K., Tanaka, A., Ozato, K., Padmanabhan, B. and Yokoyama, S. (2010a). Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem. 285, 7610-7618
49. Umehara, T., Nakamura, Y., Wakamori, M., Ozato, K., Yokoyama, S. and Padmanabhan, B. (2010b). Structural implications for K5/K12-di-acetylated histone H4 recognition by the second bromodomain of BRD2. FEBS Lett. 584, 3901-3908
50. Yang, X. J. (2004). Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26, 1076-1087.
51. Yang, Z., Yik, J. H., Chen, R., He, N., Jang, M. K., Ozato, K. and Zhou, Q. (2005). Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 19, 535-545.
52. Yang, Z., He, N. and Zhou, Q. (2008). Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol. Cell. Biol. 28, 967-976.
53. Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M. et al. (2011). RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528.